Rare genetic variants have also been described in factor H-related 5 (9), the terminal complement pathway regulator clusterin (10), thrombomodulin (11), diacylglycerol kinase epsilon (DGKE), often associated with development of HUS in infancy (12), and the fibrinolytic factor plasminogen (13). Here, DGKE is linked to hemolytic-uremic syndrome.